- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT05009771
제왕절개의 수술 후 통증 관리
제왕절개의 수술 후 통증 관리: 전향적 관찰 코호트 연구
Caesarean section is one of the most frequent surgeries causing severe postoperative pain. Poor management of acute pain can contribute to postoperative complications, late recovery and the development of chronic pain. Moreover, it had been demonstrated that the intensity of postpartum pain is associated with depression. It is imperative to find out appropriate methods of postpartum pain alleviation. Currently, a lot of analgesic drugs and methods have been developed and used in clinical practice, such as patient-controlled analgesia, extended-release analgesics and multimodal analgesia. This prospective cohort study is aimed to investigate the outcome of each postoperative analgesic method used in caesarean section.
연구 개요
상태
상세 설명
This is a prospective, observational, cohort study. Patients undergoing elective caesarean section will be invited to the study. The written informed consent will be obtained prior to participation. After getting the written informed consent, data will be collected from medical records, questionnaires, patient diaries, visit records and telephone visit records. Through telephone visits, postpartum depression scale and postpartum chronic pain will be evaluated six weeks and three months after delivery. Demographic data, consumption of analgesics, analgesic methods, intensity of postoperative pain, complications, recovery time, score of depression scale will all be summarized. Numerical variables will be present with mean and standard deviation and categorical variables will be present with number and percentage.
연구 유형
등록 (실제)
연락처 및 위치
연구 장소
-
-
-
New Taipei City, 대만, 251
- MacKay Memorial Hospital Tamsui Branch
-
Taipei, 대만, 104
- MacKay Memorial Hospital
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
샘플링 방법
연구 인구
Pregnant woman scheduled to have caesarean section within 30 days.
설명
Inclusion Criteria:
- Aged 20 to 40.
- Planing to undergo caesarean section with spinal anesthesia.
- Scheduled to undergo cesarean section between 37 and 40 weeks of gestation.
- American Society of Anesthesiology Physical Class 1-2.
- Planing to alleviate postoperative pain with intravenous patient-controlled analgesia or administration of NALDEBAIN.
Exclusion Criteria:
- Not willing to provide informed consent.
- Unable to receive opioids or NSAIDs due to contraindication.
- Long-term use of opioids or drug abuse.
- Suffering from chronic pain disease.
- Having medical history of mental illnesses.
- Diagnosed with Pre-eclampsia or eclampsia.
- Diagnosed with gestational diabetes.
- Unsuitable for participation judged by investigator.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 관찰 모델: COHORT
- 시간 관점: PROSPECTIVE
코호트 및 개입
그룹/코호트 |
개입 / 치료 |
|---|---|
|
IV-PCA + NALDEBAIN group
Patients treated with the combination of IV-PCA and intramuscular injection of dinalbuphine sebacate will be allocated to IV-PCA + NALDEBAIN group. |
At the two trial sites, IV-PCA is commonly used with morphine. The device is installed after delivery and removed within 3 days.
다른 이름들:
Dinalbuphine sebacate is a prodrug of nalbuphine. With oil-based formulation, the active ingredient releases slowly and the effect lasts longer than nalbuphine. After delivery, a single 150 mg dose of dinalbuphine sebacate is administered intramuscularly.
다른 이름들:
|
|
IV-PCA group
Patients receiving intravenous patient-controlled analgesia (IV-PCA) will be allocated to IV-PCA group. |
At the two trial sites, IV-PCA is commonly used with morphine. The device is installed after delivery and removed within 3 days.
다른 이름들:
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Postpartum pain intensity
기간: Within 5 days after delivery
|
Pain intensity is assessed by numerical rating scale (NRS) at least twice daily during hospital stay after delivery. NRS is a 11-point scale which labeled from zero (no pain) to ten (worst pain). The area under the curve of NRS are calculated. |
Within 5 days after delivery
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Consumption of analgesics
기간: Within 5 days after delivery
|
The mean total consumption of analgesics during the hospital stay after delivery. |
Within 5 days after delivery
|
|
Incidence of complications
기간: Up to 5 days after delivery
|
the incidence of postoperative complication occurring during hospital stay after delivery, especially the ones related to analgesics. |
Up to 5 days after delivery
|
|
Ambulation
기간: Up to 5 days after delivery
|
The mean length of time between delivery and the first ambulation. |
Up to 5 days after delivery
|
|
Breastfeeding
기간: Up to 5 days after delivery
|
The percentage of participants able to breastfeed during hospital stay and the mean length of time between delivery and the first breastfeeding. |
Up to 5 days after delivery
|
|
Gastrointestinal function recovery
기간: Up to 5 days after delivery
|
The mean length of time between delivery and first soft diet. |
Up to 5 days after delivery
|
|
Postnatal Depression assessment
기간: At baseline, 6 weeks and 3 months after delivery
|
Edinburgh Postnatal Depression questionnaire is used to assess patients' postpartum depression. Participants are asked to fill in the questionnaire at baseline (within 30 days prior to delivery), 6 weeks and 3 months after delivery. |
At baseline, 6 weeks and 3 months after delivery
|
|
Satisfaction assessed by a four-point scale
기간: 6 weeks after delivery
|
Participants are asked to assess the satisfaction toward rate of recovery progress and pain management through 6 questions six weeks after delivery. Each question contain 4 choices: very satisfied, satisfied, dissatisfied and very dissatisfied. |
6 weeks after delivery
|
|
Chronic pain intensity
기간: 6 weeks and 3 months after delivery
|
Chronic pain intensity is assessed by NRS 6 weeks and 3 months after delivery. NRS is a 11-point scale which labeled from zero (no pain) to ten (worst pain). |
6 weeks and 3 months after delivery
|
공동 작업자 및 조사자
수사관
- 수석 연구원: Chi-Hsu Wang, M.D., MacKay Memorial Hospital Tamsui Branch
간행물 및 유용한 링크
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .